What can the European Multicenter Trial on the treatment of Graves' disease with antithyroid drugs teach us about the course of thyroid-associated orbitopathy (TAO)? European Multicenter Trial Group.
Benker
G
G
Merck KGaA, Department CRDO/DS Darmstadt, Germany.
Kahaly
G J
GJ
Reinwein
D
D
D000293:Adolescent; D000328:Adult; D000368:Aged; D000375:Aging / Q000502:physiology; D013956:Antithyroid Agents / Q000627:therapeutic use*; D018450:Disease Progression; D004305:Dose-Response Relationship, Drug; D005139:Eyeglasses; D006111:Graves Disease / Q000188:drug therapy* / Q000503:physiopathology / Q000628:therapy; D006801:Humans; D008875:Middle Aged; D015995:Prevalence
D013956:Antithyroid Agents